Group 1 - Zhejiang Wenchuang Internet focuses on digital marketing and cultural technology, integrating AI into smart marketing and digital content creation, enhancing brand marketing digital transformation across various industries [1][17] - Saiwu Technology collaborates with Suzhou University to establish the AI4S laboratory, creating a closed loop of "AI screening - process optimization - mass production," significantly increasing revenue in related businesses [1][18] - Huashi Technology strategically invests in Yuchuang Robotics, applying AI in various scenarios such as airport monitoring and risk warning, providing intelligent solutions for smart cities [1][19] Group 2 - Yidian Tianxia leverages AI for global smart marketing, developing a full-chain solution that includes multi-language digital content generation and intelligent ad optimization [2][18] - Tongda Hai builds a comprehensive legal knowledge graph using vast legal data, enhancing judicial efficiency through its self-developed AI platform [2][19] - Sanwei Communication's subsidiary, Juwang Technology, utilizes AI for advertising material generation and optimization, significantly improving marketing efficiency [2][19] Group 3 - BlueFocus is a leader in AI marketing, applying AI across the entire marketing chain, including creative generation and effect analysis, to drive digital transformation in the marketing industry [3][19] - Huashu Media actively promotes AI integration in broadcasting, enhancing user experience through smart content recommendations and network optimization [3][20] - Subot constructs a cross-disciplinary platform for material and intelligent mechanics, driving high-end material development and optimizing production processes [3][20] Group 4 - Shiji Tianhong integrates AI into education, enhancing digital transformation in educational support services through intelligent systems [4][20] - Hongbo Pharmaceutical's AI drug design platform focuses on cyclic peptide drug development, significantly improving drug design efficiency and accuracy [5][21] - Tianlong Group's self-developed platform empowers digital marketing across various industries, enhancing customer acquisition and conversion rates [5][21] Group 5 - Yanshan Technology integrates AI into internet services and supply chain management, optimizing marketing and operational efficiency [6][22] - ChaoTu Software merges AI with GIS, enabling intelligent spatial data processing and analysis for smart city applications [6][22] - Heren Technology focuses on smart healthcare, developing AI systems to assist medical personnel and improve operational efficiency [6][23] Group 6 - Youzu Network applies AI throughout game development and operation, enhancing player engagement and experience [6][23] - Jinka Intelligent integrates AI into gas metering, improving management efficiency and safety in gas supply [7][24] - Liard incorporates AI into display technology, optimizing visual experiences and expanding applications in smart displays [7][24] Group 7 - Guanshang Technology focuses on military equipment lifecycle management using AI for fault diagnosis and training simulation [7][25] - Zhidema applies AI in consumer decision-making and e-commerce marketing, enhancing product recommendations and marketing strategies [7][25] - Runda Medical enhances laboratory testing processes with AI, improving detection accuracy and efficiency [7][25] Group 8 - Tiandi Online specializes in digital marketing, utilizing AI for user profiling and intelligent ad targeting [8][26] - Qianfang Technology focuses on smart transportation, developing AI systems for traffic management and vehicle recognition [8][26] - Jiaxun Feihong integrates AI into communication and rail transit, enhancing operational efficiency and safety [8][26] Group 9 - Jiadu Technology applies AI in smart city and rail transit, enhancing safety monitoring and automation [8][27] - Jiuzhoutong empowers pharmaceutical supply chains with AI for demand forecasting and inventory management [8][27] - Weining Health focuses on comprehensive smart healthcare solutions, enhancing operational efficiency and cost control [8][27] Group 10 - Dianke Digital strengthens IT service capabilities with AI, focusing on data center operations and security [8][28] - Guangting Information specializes in intelligent connected vehicles, developing AI systems for driving assistance and data governance [8][28] - Rongxin Culture integrates AI into children's publishing, enhancing reading experiences and content creation [8][29] Group 11 - Zhaochi Co. introduces AI in consumer electronics and lighting, optimizing product performance and supply chain management [8][29] - Jinxiandai focuses on industrial software, enhancing digital transformation through AI-assisted development and operations [8][30] - Huatu Shanding integrates AI into architectural design, improving efficiency and precision in building projects [8][30] Group 12 - Lakala enhances payment services with AI, improving transaction security and merchant support [8][30] - Yingjianke focuses on building design software, utilizing AI for structural optimization and efficiency [8][30] - Borui Communication empowers media and digital culture with AI, enhancing content delivery and user engagement [8][31] Group 13 - Haoyun Technology enhances security IoT with AI, providing risk assessment and decision support [8][31] - Shenguang Group leverages AI for digital marketing, optimizing user targeting and ad performance [8][31] - Oriental Pearl actively promotes AI in broadcasting, enhancing content production and user experience [8][31] Group 14 - Zhizhen Technology focuses on IT operations in communication and government sectors, utilizing AI for efficient management [8][32]

Market Overview - The pharmaceutical commercial sector experienced a decline of 0.48% on January 20, with Luyuan Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] Stock Performance - Notable gainers in the pharmaceutical sector included: - Guofa Co., Ltd. (600538) with a closing price of 6.87, up 3.46% and a trading volume of 245,400 shares, totaling 168 million yuan [1] - Huaren Health (301408) closed at 22.08, up 1.38% with a trading volume of 317,600 shares, totaling 700 million yuan [1] - Conversely, significant decliners included: - Jianghe Pharmaceutical (002788) with a closing price of 16.64, down 6.04% and a trading volume of 872,500 shares, totaling 1.465 billion yuan [2] - Yingte Group (000411) closed at 13.84, down 2.40% with a trading volume of 230,300 shares, totaling 316 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 497 million yuan from institutional investors and a net outflow of 109 million yuan from speculative funds, while retail investors had a net inflow of 607 million yuan [2] - Key stocks with notable capital flows included: - Huaren Health (301408) with a net inflow of 46.16 million yuan from institutional investors, but a net outflow of 48.48 million yuan from retail investors [3] - Yifeng Pharmacy (603939) had a net inflow of 21.74 million yuan from institutional investors, but also saw a net outflow of 1.63 million yuan from retail investors [3]

Core Insights - The article discusses the transformation of China's healthcare system through the implementation of the open-source HarmonyOS, which is enhancing the efficiency and interconnectivity of hospital operations [1][2][3]. Group 1: Technological Advancements - The Chongqing Liangjiang New Area People's Hospital has implemented a smart system based on HarmonyOS, allowing real-time monitoring of patient status and significantly improving response times to incidents [1][3]. - The system integrates various devices, creating a seamless data flow across the hospital, which enhances patient autonomy and reduces the workload on nursing staff [2][3]. - The deployment of over 3,000 terminal devices has reduced incident response times from minutes to seconds and increased the satisfaction rate of personalized patient needs by approximately 80% [3]. Group 2: Systemic Challenges and Solutions - Traditional healthcare models face inefficiencies due to fragmented information flow and reliance on manual processes, leading to increased costs and wasted resources [2]. - The adoption of HarmonyOS is seen as a strategic choice that allows for customized development tailored to specific medical needs, overcoming limitations of traditional closed systems [3][5]. Group 3: Broader Implications for Healthcare - The transformation is not limited to new facilities; existing hospitals are also undergoing upgrades using HarmonyOS, which is facilitating a comprehensive reconfiguration of healthcare services [4][5]. - The integration of AI and HarmonyOS is expected to create a new ecosystem in healthcare, enhancing data security and system autonomy, which is crucial for the future of the industry [5][6]. Group 4: Industry Engagement - Several listed companies are actively investing in HarmonyOS-based healthcare solutions, indicating a growing interest in the intersection of AI and healthcare [6][7]. - Companies like Xiamen Dinake and Jiangsu Runkai Hong Digital Technology are developing innovative solutions that leverage HarmonyOS for integrated healthcare services, showcasing the potential for industry-wide transformation [6][7].

上海润达医疗科技股份有限公司 关于2025年年度业绩预告的提示性 公告 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603108 证券简称：润达医疗 公告编号：临2026-010 转债代码：113588 转债简称：润达转债 公司指定的信息披露媒体为《中国证券报》、《上海证券报》、《证券日报》、《证券时报》及上海证 券交易所网站（www.sse.com.cn），有关公司信息均以公司在上述指定媒体披露信息为准。敬请广大投 资者理性投资，注意投资风险。 特此公告。 上海润达医疗科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 经上海润达医疗科技股份有限公司（以下简称"公司"）财务部门初步核算，预计2025年年度归属于上市 公司股东的净利润为负值，公司2025年年度经营业绩将出现亏损。 公司将严格遵循《上海证券交易所股票上市规则》等相关规定，加快推进财务核算工作，尽快披露2025 年年度业绩预告。最终财务数据请以公司正式披露的2025年年度报告为准。 董事会 2026年1月16日 ...

润达医疗表示，公司将严格遵循《上海证券交易所股票上市规则》等相关规定，加快推进财务核算工 作，尽快披露2025年年度业绩预告。最终财务数据以公司正式披露的2025年年度报告为准。 北京商报讯（记者 丁宁）1月16日晚间，润达医疗（603108）发布公告称，经公司财务部门初步核算， 预计2025年年度归属净利润为负值，公司2025年年度经营业绩将出现亏损。 ...

证券日报网讯 1月16日，润达医疗发布公告称，公司预计2025年年度归属于上市公司股东的净利润为负 值，公司2025年年度经营业绩将出现亏损。 （文章来源：证券日报） ...

润达医疗（603108）(603108.SH)发布公告，经公司财务部门初步核算，预计2025年年度归属于上市公 司股东的净利润为负值，公司2025年年度经营业绩将出现亏损。 ...

智通财经APP讯，润达医疗(603108.SH)发布公告，经公司财务部门初步核算，预计2025年年度归属于 上市公司股东的净利润为负值，公司2025年年度经营业绩将出现亏损。 ...

| 证券代码：603108 | 证券简称：润达医疗 | 公告编号：临 2026-010 | | --- | --- | --- | | 转债代码：113588 | 转债简称：润达转债 | | 上海润达医疗科技股份有限公司 关于 2025 年年度业绩预告的提示性公告 经上海润达医疗科技股份有限公司（以下简称"公司"）财务部门初步核算， 预计 2025 年年度归属于上市公司股东的净利润为负值，公司 2025 年年度经营业 绩将出现亏损。 公司将严格遵循《上海证券交易所股票上市规则》等相关规定，加快推进财 务核算工作，尽快披露 2025 年年度业绩预告。最终财务数据请以公司正式披露 的 2025 年年度报告为准。 公司指定的信息披露媒体为《中国证券报》、《上海证券报》、《证券日报》、 《证券时报》及上海证券交易所网站（www.sse.com.cn），有关公司信息均以公 司在上述指定媒体披露信息为准。敬请广大投资者理性投资，注意投资风险。 特此公告。 上海润达医疗科技股份有限公司 2026 年 1 月 16 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确 ...

21智讯1月16日电，润达医疗发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为负 值，公司2025年年度经营业绩将出现亏损。原因：经上海润达医疗科技股份有限公司（以下简称"公 司"）财务部门初步核算，预计2025年年度归属于上市公司股东的净利润为负值，公司2025年年度经营 业绩将出现亏损。公司将严格遵循《上海证券交易所股票上市规则》等相关规定，加快推进财务核算工 作，尽快披露2025年年度业绩预告。最终财务数据请以公司正式披露的2025年年度报告为准。 ...